Table 1.
Effects of YC on characteristics of sperm, seminiferous tubules, serum testosterone, body weight, and the relative testicular and epididymal weights.
| Parameters | Control | CP | CP + YC (630 mg/kg) | CP + YC (1260 mg/kg) |
|---|---|---|---|---|
| Sperm count (×106 mL−1) | 82.56 ± 7.49 | 43.94 ± 4.70∗∗ | 51.31 ± 2.67# | 65.11 ± 8.18## |
| Sperm motility (%) | 69.00 ± 6.22 | 45.76 ± 7.28∗∗ | 62.22 ± 4.68## | 65.25 ± 7.06## |
| Proportion of damaged tubules (%) | 2.9 ± 2.3 | 75.1 ± 5.3∗∗ | 20.5 ± 7.6## | 13.3 ± 6.1## |
| Body weight (g) | 29.11 ± 1.54 | 26.0 ± 1.41∗∗ | 26.50 ± 1.41 | 28.11 ± 1.76## |
| Relative testicular weight (mg/g bodyweight) | 4.02 ± 0.28 | 2.75 ± 0.54∗∗ | 3.13 ± 0.29 | 3.32 ± 0.39## |
| Relative epididymal weight (mg/g bodyweight) | 1.47 ± 0.20 | 1.10 ± 0.11∗∗ | 1.44 ± 0.13## | 1.37 ± 0.12## |
| Testosterone (mol/L) | 1.81 ± 0.86 | 0.56 ± 0.22∗ | 0.61 ± 0.26 | 0.76 ± 0.35 |
Data are expressed as the mean ± SD (n = 9). ∗ P < 0.05, ∗∗ P < 0.01 compared to the control group; # P < 0.05, ## P < 0.01 compared to the CP-treated group.
CP: cyclophosphamide; SD: standard deviation; YC: Yangjing capsule.